KBP Biosciences Usa

Parent

KBP Biosciences is a global, clinical-stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved patient populations in organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the company to efficiently bring new therapies from bench to patients around the world. Our lead product candidate, KBP-5074, is a third-generation non-steroidal mineralocorticoid receptor antagonist (MRA) with potentially best-in-class safety and efficacy profile. At KBP Biosciences we are dedicated to push the boundaries of science to transform the lives of patients around the world. We are dedicated to delivering value to our communities, our employees, and the environment. We are responsible for our actions on people and the planet. We are also mindful of our social responsibilities, and committed to high standards of governance.

Chemical entities, biopharmaceutical, non-steroidal mineralocorticoid, (MRA), Disease Areas, new chemical, infectious diseases

Princeton, NJ
United States